Table 4. Multivariate analysis (Cox model) on progression-free survival and overall survival of all patients.
|
Progression-free survival
|
Overall survival
|
|||||
|---|---|---|---|---|---|---|
| Variable | RR | 95% CI of RR | P-value | RR | 95% CI of RR | P-value |
| Patient age <70 years/⩾70years | 4.40 | (1.75–11.08) | 0.004 | — | — | NS |
| Clinical stage (T1–T2/T3–T4) | 2.65 | (1.17–6.0) | 0.012 | 3.44 | (1.45–8.17) | 0.002 |
| Nodal status (N0/N+) | — | — | — | — | — | NS |
| VEGF-A expression (</⩾ median) | 3.16 | (1.54–6.48) | 0.001 | 3.61 | (1.70–7.65) | 0.0004 |
RR: relative risk, CI: confidence interval, NS: not significant; VEGF, Vascular endothelial growth factor A.